A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
The advance of next-generation sequencers (NGS) has dramatically improved the performance of genomic analysis of clinical samples in cancer precision medicine. The practical use of gene panel testing for clinical applications has begun in Japan. At present, "OncomineTM Dx Target Test" is listed as a companion diagnostic system using NGS, and "FoundationOne CDx Cancer Genomic Profile" and "OncoGuide™ NCC Oncopanel System" are listed as gene panel testing under insurance coverage. Formalin-fixeddoi:10.1093/noajnl/vdz039.011 fatcat:t3s3tlhwqnhwpiqsozyeqj2uxi